- Home
- ENLV vs ASPS Comparison
ENLV vs ASPS Comparison
Compare ENLV & ASPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- ASPS
- Stock Information
- Founded
- ENLV 2005
- ASPS 1999
- Country
- ENLV Israel
- ASPS Luxembourg
- Employees
- ENLV N/A
- ASPS N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- ASPS Other Consumer Services
- Sector
- ENLV Health Care
- ASPS Consumer Discretionary
- Exchange
- ENLV Nasdaq
- ASPS Nasdaq
- Market Cap
- ENLV 23.7M
- ASPS 9.2M
- IPO Year
- ENLV 1995
- ASPS N/A
- Fundamental
- Price
- ENLV $1.13
- ASPS $9.78
- Analyst Decision
- ENLV Strong Buy
- ASPS
- Analyst Count
- ENLV 2
- ASPS 0
- Target Price
- ENLV $10.00
- ASPS N/A
- AVG Volume (30 Days)
- ENLV 101.3K
- ASPS 68.0K
- Earning Date
- ENLV 08-29-2025
- ASPS 07-24-2025
- Dividend Yield
- ENLV N/A
- ASPS N/A
- EPS Growth
- ENLV N/A
- ASPS N/A
- EPS
- ENLV N/A
- ASPS N/A
- Revenue
- ENLV N/A
- ASPS $164,104,000.00
- Revenue This Year
- ENLV N/A
- ASPS $38.29
- Revenue Next Year
- ENLV N/A
- ASPS N/A
- P/E Ratio
- ENLV N/A
- ASPS N/A
- Revenue Growth
- ENLV N/A
- ASPS 13.12
- 52 Week Low
- ENLV $0.81
- ASPS $3.46
- 52 Week High
- ENLV $1.76
- ASPS $13.12
- Technical
- Relative Strength Index (RSI)
- ENLV 62.52
- ASPS 60.61
- Support Level
- ENLV $0.90
- ASPS $8.45
- Resistance Level
- ENLV $1.30
- ASPS $11.07
- Average True Range (ATR)
- ENLV 0.09
- ASPS 0.91
- MACD
- ENLV 0.01
- ASPS -0.05
- Stochastic Oscillator
- ENLV 70.00
- ASPS 52.94
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.